Türkoğlu, R. Et Al. 2022. Fingolimod impairs inactivated vaccine (CoronaVac)-induced antibody response to SARS-CoV-2 spike protein in persons with multiple sclerosis.. Multiple sclerosis and related disorders , vol.58 , 103524.

Türkoğlu, R., Baliç, N., Kızılay, T., Erol, R., Akbayır, E., Yılmaz, V., ... Tüzün, E.(2022). Fingolimod impairs inactivated vaccine (CoronaVac)-induced antibody response to SARS-CoV-2 spike protein in persons with multiple sclerosis.. Multiple sclerosis and related disorders , vol.58, 103524.

Türkoğlu, Recai Et Al. "Fingolimod impairs inactivated vaccine (CoronaVac)-induced antibody response to SARS-CoV-2 spike protein in persons with multiple sclerosis.," Multiple sclerosis and related disorders , vol.58, 103524, 2022

Türkoğlu, Recai Et Al. "Fingolimod impairs inactivated vaccine (CoronaVac)-induced antibody response to SARS-CoV-2 spike protein in persons with multiple sclerosis.." Multiple sclerosis and related disorders , vol.58, pp.103524, 2022

Türkoğlu, R. Et Al. (2022) . "Fingolimod impairs inactivated vaccine (CoronaVac)-induced antibody response to SARS-CoV-2 spike protein in persons with multiple sclerosis.." Multiple sclerosis and related disorders , vol.58, p.103524.

@article{article, author={Recai Türkoğlu Et Al. }, title={Fingolimod impairs inactivated vaccine (CoronaVac)-induced antibody response to SARS-CoV-2 spike protein in persons with multiple sclerosis.}, journal={Multiple sclerosis and related disorders}, year=2022, pages={103524} }